Drug-maker Cipla today reported a 40.41 per cent rise in consolidated net profit to Rs 1,082.59 crore for the year ended March, 2010, compared to Rs 771.02 crore in the previous fiscal.
The company has recommended a dividend of Rs 2 per share of Rs 2 face value for the year 2009-10, which will entail an outgo of Rs 160.58 crore.
Total operating income for the year ended March, 2010, stood at Rs 5,624.91 crore, compared to Rs 5,246.07 crore in the previous fiscal, the company said in a statement.
In March, 2010, the company sold the intellectual property rights and technical know-how for 'i-pill', an emergency contraceptive brand, to Piramal Healthcare for a consideration of Rs 95 crore.
Shares of Cipla today closed at Rs 337.85 on the BSE, down 0.69 per cent from the previous close.